It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Microcirculatory dysfunction occurs early in cardiovascular disease (CVD) development. Acute myocardial infarction (MI) is a late consequence of CVD. The conjunctival microcirculation is readily-accessible for quantitative assessment and has not previously been studied in MI patients. We compared the conjunctival microcirculation of acute MI patients and age/sex-matched healthy controls to determine if there were differences in microcirculatory parameters. We acquired images using an iPhone 6s and slit-lamp biomicroscope. Parameters measured included diameter, axial velocity, wall shear rate and blood volume flow. Results are for all vessels as they were not sub-classified into arterioles or venules. The conjunctival microcirculation was assessed in 56 controls and 59 inpatients with a presenting diagnosis of MI. Mean vessel diameter for the controls was 21.41 ± 7.57 μm compared to 22.32 ± 7.66 μm for the MI patients (p < 0.001). Axial velocity for the controls was 0.53 ± 0.15 mm/s compared to 0.49 ± 0.17 mm/s for the MI patients (p < 0.001). Wall shear rate was higher for controls than MI patients (162 ± 93 s−1 vs 145 ± 88 s−1, p < 0.001). Blood volume flow did not differ significantly for the controls and MI patients (153 ± 124 pl/s vs 154 ± 125 pl/s, p = 0.84). This pilot iPhone and slit-lamp assessment of the conjunctival microcirculation found lower axial velocity and wall shear rate in patients with acute MI. Further study is required to correlate these findings further and assess long-term outcomes in this patient group with a severe CVD phenotype.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Belfast Health and Social Care Trust, Department of Cardiology, Royal Victoria Hospital, Belfast, UK (GRID:grid.412915.a) (ISNI:0000 0000 9565 2378); Ulster University, Biomedical Sciences Research Institute, Coleraine, UK (GRID:grid.12641.30) (ISNI:0000000105519715)
2 Ulster University, Biomedical Sciences Research Institute, Coleraine, UK (GRID:grid.12641.30) (ISNI:0000000105519715)
3 Ulster University, Nanotechnology and Integrated Bioengineering Centre (NIBEC), Jordanstown, UK (GRID:grid.12641.30) (ISNI:0000000105519715)
4 Belfast Health and Social Care Trust, Department of Cardiology, Royal Victoria Hospital, Belfast, UK (GRID:grid.412915.a) (ISNI:0000 0000 9565 2378)
5 University of Dundee, VAMPIRE project, Computing (SSEN), Dundee, UK (GRID:grid.8241.f) (ISNI:0000 0004 0397 2876)




